Notably, the NS CSF proteomic profile showed substantial pathway-level convergence with that reported in <i>MECP2</i> duplication syndrome (MDS), an X-linked neurodevelopmental disorder marked by <i>MECP2</i> overexpression and systemic immune-metabolic dysfunction. The gene discussed is MECP2; the disease is myelodysplastic syndrome.